A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

April 1, 2025

Study Completion Date

July 1, 2025

Conditions

Diabetes Mellitus

Interventions

RADIATION

68Ga-NODAGA-exendin-4 PET/CT

Trial Locations (2)

RECRUITING

University of Vienna, Vienna

RECRUITING

Assistance Publique hopitaux de Paris, Paris

All Listed Sponsors

collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

collaborator

Medical University of Vienna

OTHER

collaborator

Bart's London

UNKNOWN

collaborator

KU Leuven

OTHER

lead

Radboud University Medical Center

OTHER